Deep phenotyping of T cell populations under long‐term treatment of tacrolimus and rapamycin in patients receiving renal transplantations by mass cytometry
Abstract Tacrolimus (FK506) and rapamycin (RAPA) are widely used to maintain long‐term immunosuppression after organ transplantation. However, the impact of accumulative drug administration on the recipients’ immune systems remains unclear. We investigated the impact of 3‐year FK506 or RAPA treatmen...
Enregistré dans:
Auteurs principaux: | Yiyang Li, Huimin An, Chuan Shen, Boqian Wang, Ting Zhang, Yifan Hong, Hui Jiang, Peijun Zhou, Xianting Ding |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/66b51bd9d55845f2b66e44d42a9f19df |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients
par: Lekshmy Srinivas, et autres
Publié: (2021) -
Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
par: Cheng F, et autres
Publié: (2021) -
Rescate con Sirolimus por rechazo agudo recurrente y diabetes mellitus en trasplante hepático: Caso clínico pediátrico
par: Roque E,Jorge, et autres
Publié: (2005) -
A single‐center, open‐label, randomized cross‐over study to evaluate the pharmacokinetics and bioavailability of once‐daily prolonged‐release formulations of tacrolimus in de novo liver transplant recipients
par: Uta Herden, et autres
Publié: (2021) -
Retiro precoz de esteroides en la inmunosupresión del trasplante renal pediátrico
par: Delucchi B,Angela, et autres
Publié: (2006)